Cholestasis of Pregnancy: Clinical and Laboratory Studies

Authors

  • Bertel Berg M.D.,

    Corresponding author
    1. Department of Clinical Chemistry, Central Hospital, Kristianstad
    2. Department of Obstetrics and Gynecology, Central Hospital, Kristianstad
    3. Department of Obstetrics and Gynecology, University of Lund, Lund, Sweden
    Search for more papers by this author
  • Göran Helm,

    1. Department of Clinical Chemistry, Central Hospital, Kristianstad
    2. Department of Obstetrics and Gynecology, Central Hospital, Kristianstad
    3. Department of Obstetrics and Gynecology, University of Lund, Lund, Sweden
    Search for more papers by this author
  • Lennart Petersohn,

    1. Department of Clinical Chemistry, Central Hospital, Kristianstad
    2. Department of Obstetrics and Gynecology, Central Hospital, Kristianstad
    3. Department of Obstetrics and Gynecology, University of Lund, Lund, Sweden
    Search for more papers by this author
  • Nils Tryding

    1. Department of Clinical Chemistry, Central Hospital, Kristianstad
    2. Department of Obstetrics and Gynecology, Central Hospital, Kristianstad
    3. Department of Obstetrics and Gynecology, University of Lund, Lund, Sweden
    Search for more papers by this author

Department of Clinical Chemistry, Central Hospital, S - 291 85 Kristianstad, Sweden

Abstract

A prospective study was made of clinical symptoms, liver function and pregnancy prognosis in women with cholestasis of pregnancy (CP). We used several positive and negative criteria to allow a clinical definition of CP as itching limited to time of pregnancy with or without laboratory evidence of liver dysfunction. the incidence during 1971–74 was 1.5% (100/6798 women) and lower during 1980–82 (52/5 441 = 1.0%). One hundred consecutive pregnant women without itching were used as clinical controls. the incidence of CP showed a distinct seasonal variation, culminating in November. Women with CP had often had itching during previous pregnancies and during use of contraceptive pills and described anamnestically itching in mother and sisters. Laboratory data in CP were compared with reference intervals for healthy pregnant women. Serum enzyme levels were significantly increased for serum alkaline phosphatase, 5-nucleotidase, aspartate aminotrans-ferase and alanine aminotransferase in the second and especially in the third trimester. the enzyme distribution was often markedly skewed to the right, i.e. some patients reacted more than others. Most patients with cholestasis only had itching without pronounced abnormalities in laboratory data. This mild form of CP was associated with a good prognosis for both mother and child.

Ancillary